These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9793870)

  • 21. Schizophrenia and antipsychotic somatic treatment.
    Lindström LH; Wieselgren IM
    Int J Technol Assess Health Care; 1996; 12(4):573-84. PubMed ID: 9136468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.
    Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders
    Aust N Z J Psychiatry; 2005; 39(1-2):1-30. PubMed ID: 15660702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving outcome in schizophrenia: the case for early intervention.
    Malla AK; Norman RM; Voruganti LP
    CMAJ; 1999 Mar; 160(6):843-6. PubMed ID: 10189434
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples.
    Gaebel W; Stricker J; Riesbeck M
    Schizophr Res; 2020 Nov; 225():4-14. PubMed ID: 31806527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New drugs for schizophrenia: an update for family physicians.
    Amadio PB; Cross LB; Amadio P
    Am Fam Physician; 1997 Sep; 56(4):1149-56, 1159-60. PubMed ID: 9310066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.
    Glick ID; Zamora D; Kamis D; Davis JM
    CNS Spectr; 2019 Oct; 24(5):557-563. PubMed ID: 30777584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.
    Keefe RS; Mohs RC; Bilder RM; Harvey PD; Green MF; Meltzer HY; Gold JM; Sano M
    Schizophr Bull; 2003; 29(1):45-55. PubMed ID: 12908660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?
    Harrow M; Jobe TH
    Schizophr Bull; 2013 Sep; 39(5):962-5. PubMed ID: 23512950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptics and the natural course of schizophrenia.
    Wyatt RJ
    Schizophr Bull; 1991; 17(2):325-51. PubMed ID: 1679255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penfluridol for schizophrenia.
    Soares BG; Lima MS
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002923. PubMed ID: 16625563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting injectable antipsychotics in early psychosis: a literature review.
    Emsley R; Chiliza B; Asmal L; Mashile M; Fusar-Poli P
    Early Interv Psychiatry; 2013 Aug; 7(3):247-54. PubMed ID: 23342964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications for long-term pharmacological treatment of schizophrenic syndromes.
    Perris C
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):149-58. PubMed ID: 10585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment.
    Thomas LE; Woods SW
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):109-33. PubMed ID: 16321727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications.
    Green MF; Braff DL
    Biol Psychiatry; 2001 Feb; 49(4):374-84. PubMed ID: 11239909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for clinical treatment of early course schizophrenia.
    Keshavan MS; Roberts M; Wittmann D
    Curr Psychiatry Rep; 2006 Aug; 8(4):329-34. PubMed ID: 16879798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic treatment response in schizophrenia.
    Gardner KN; Bostwick JR
    Am J Health Syst Pharm; 2012 Nov; 69(21):1872-9. PubMed ID: 23111671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.